Lv7
5000 积分 2021-08-12 加入
New immune cell engagers for cancer immunotherapy
1个月前
已完结
The preclinical discovery and clinical development of ciltacabtagene autoleucel (Cilta-cel) for the treatment of multiple myeloma
1个月前
已完结
General strategies for IgG‐like bispecific antibody purification
4个月前
已完结
In vivo detection of immune responses via cytokine activity labeling
4个月前
已完结
Linking tumour angiogenesis and tumour immunity
4个月前
已完结
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
4个月前
已完结
The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases
5个月前
已完结
mRNA-based therapies: Preclinical and clinical applications
5个月前
已完结
Targeted delivery of IFN-α-anti-GPC3 fusion protein via mRNA-LNP platform elicits potent anti-tumor immunity in hepatocellular carcinoma
5个月前
已完结
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
5个月前
已完结
皖公网安备34019202002308
